MapLight Therapeutics, Inc.: Chief scientific officer Lillie Woodruff sold 11,513 shares

What happened

• The filing reports that Lillie James Woodruff, chief scientific officer, sold 11,513 shares on Oct 15, 2026 for aggregate proceeds of $93,025 at a weighted average price of $8.08 per share. The transaction is reported as an open market or private sale (code S).
• The sale was conducted to cover statutory tax withholding obligations associated with the vesting of restricted stock units, as required under the issuer's election under its equity incentive plans (footnote F1).

Key details

• Transaction date: Oct 15, 2026; filing date: Oct 16, 2026.
• Shares sold: 11,513; weighted average price reported: $8.08 per share; price range across multiple trades: $7.755 to $8.3732 per share (footnote F2).
• Shares owned after the transaction: not provided in the filing summary supplied here.
• Footnotes: F1 — sale mandated as a "sell to cover" to satisfy minimum statutory tax withholding; F2 — reported price is a weighted average and the reporting person will provide a breakdown of shares sold at each price on request.
• Filing timeliness: filed the day after the transaction (no lateness indicator provided).

Why it may matter

• The filing indicates this was a sell-to-cover transaction tied to RSU vesting, not described as a discretionary open-market sale by the reporting person.
• This filing does not show why the insider traded or why the company acted.